CINECA IRIS Institutional Research Information System

ANTONIOLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.690
AS - Asia 7.503
EU - Europa 6.623
SA - Sud America 1.139
AF - Africa 385
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.260
IT - Italia 2.686
SG - Singapore 2.435
CN - Cina 1.970
HK - Hong Kong 1.230
BR - Brasile 953
SE - Svezia 825
VN - Vietnam 641
DE - Germania 570
BG - Bulgaria 452
GB - Regno Unito 384
FI - Finlandia 323
FR - Francia 289
CA - Canada 283
TR - Turchia 277
RU - Federazione Russa 271
AT - Austria 256
IN - India 209
JP - Giappone 165
CI - Costa d'Avorio 148
UA - Ucraina 123
NL - Olanda 119
KR - Corea 107
MX - Messico 79
PL - Polonia 77
AR - Argentina 72
CH - Svizzera 64
IQ - Iraq 63
PK - Pakistan 62
BD - Bangladesh 61
BE - Belgio 46
SN - Senegal 46
UZ - Uzbekistan 39
ZA - Sudafrica 38
ID - Indonesia 37
NG - Nigeria 37
ES - Italia 30
VE - Venezuela 29
IR - Iran 26
MA - Marocco 26
SA - Arabia Saudita 26
EC - Ecuador 25
AU - Australia 24
EG - Egitto 22
CO - Colombia 21
PH - Filippine 20
KE - Kenya 17
CZ - Repubblica Ceca 16
AE - Emirati Arabi Uniti 15
LT - Lituania 14
PY - Paraguay 14
AZ - Azerbaigian 13
JM - Giamaica 13
MY - Malesia 13
TW - Taiwan 13
DZ - Algeria 11
IE - Irlanda 11
PT - Portogallo 11
TN - Tunisia 11
CL - Cile 10
IL - Israele 10
JO - Giordania 9
LB - Libano 9
PA - Panama 9
AL - Albania 8
NO - Norvegia 8
BJ - Benin 7
HN - Honduras 7
KZ - Kazakistan 7
OM - Oman 7
PE - Perù 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
HU - Ungheria 6
KG - Kirghizistan 6
RS - Serbia 6
UY - Uruguay 6
BY - Bielorussia 5
GR - Grecia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
RO - Romania 5
TT - Trinidad e Tobago 5
CG - Congo 4
DK - Danimarca 4
GD - Grenada 4
GH - Ghana 4
NI - Nicaragua 4
NP - Nepal 4
QA - Qatar 4
SV - El Salvador 4
AO - Angola 3
BS - Bahamas 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
LV - Lettonia 3
MO - Macao, regione amministrativa speciale della Cina 3
TH - Thailandia 3
Totale 31.344
Salva come PNG Salva come JPEG
Città #
Ashburn 1.646
Singapore 1.341
Fairfield 1.262
Hong Kong 1.190
Woodbridge 1.175
Dallas 1.009
Ann Arbor 940
San Jose 901
Houston 851
Santa Clara 790
Chandler 782
Seattle 498
Wilmington 480
Cambridge 448
Sofia 446
Shanghai 440
Milan 439
Beijing 400
Serra 376
New York 341
Boardman 267
Los Angeles 243
Council Bluffs 216
Princeton 192
Ottawa 190
Pisa 178
Vienna 174
Lawrence 168
Lauterbourg 161
Florence 151
Medford 150
Abidjan 148
Tokyo 137
Ho Chi Minh City 132
Izmir 131
Jacksonville 122
Helsinki 121
Munich 121
Hefei 118
Dong Ket 116
Hanoi 112
Rome 112
Des Moines 109
London 107
Istanbul 93
Nanjing 93
Chicago 90
Frankfurt am Main 90
Seoul 86
São Paulo 85
Buffalo 84
Bremen 81
Redondo Beach 74
Dearborn 73
Turku 57
Lucca 55
Lappeenranta 50
Nanchang 49
Warsaw 47
Columbus 46
Dakar 46
Lancaster 46
Ogden 44
Brussels 43
San Diego 41
Redwood City 40
Falls Church 39
The Dalles 38
Tashkent 35
Atlanta 34
Lagos 34
Washington 34
Chennai 32
Naples 32
Nuremberg 32
Orem 30
Toronto 30
Boulder 29
Zurich 29
Bern 28
Phoenix 28
Bologna 27
Montignoso 27
Montreal 27
Pune 27
Rio de Janeiro 27
Guangzhou 26
Changsha 24
Livorno 24
Tianjin 24
Kunming 23
Marseille 23
Amsterdam 22
Brooklyn 22
Fuzhou 22
Hebei 22
Da Nang 21
Porto Alegre 21
Baghdad 20
Belo Horizonte 20
Totale 21.777
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 539
Preparation of isoindoline derivatives for use as AMPK activators 346
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 305
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 293
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 274
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 272
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 267
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 251
Derivati benzofuranici come attivatori di AMPK 250
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 234
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 231
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 230
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 226
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 216
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 216
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 211
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 211
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 208
CD39 and CD73 in immunity and inflammation 207
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 205
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 204
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 204
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 203
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 199
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 198
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 198
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 198
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 197
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 197
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 196
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 195
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 195
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 194
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 194
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 193
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 193
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 193
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 192
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 192
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 190
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 190
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 187
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 186
Role of A2a adenosine in the regulation of colonic motility in normal human colon 185
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 185
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 185
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 184
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 183
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 182
Preparation of benzofuran derivatives for use as AMPK activators 182
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 182
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 180
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 179
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 179
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 178
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 178
Donepezil improves vascular function in a mouse model of Alzheimer's disease 178
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 177
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 176
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 176
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 175
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 174
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 174
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 172
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 172
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 172
Allopurinol adherence among patients with gout: an Italian general practice database study 172
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 172
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 170
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 169
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 169
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 168
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 167
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 167
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 167
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 167
The intestinal barrier in disorders of the central nervous system 166
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 163
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 162
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 162
Transient acute liver failure complicating transurethral resection syndrome 162
Adenosine and inflammation: what's new on the horizon? 161
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 160
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 160
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms 159
Anti-CD73 in cancer immunotherapy: awakening new opportunities 158
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 157
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 157
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 156
Risankizumab for the treatment of moderate to severe psoriasis 156
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 155
Adenosine signaling in the tumor microenvironment 154
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 153
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 153
Totale 19.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.056 37 87 66 105 390 307 74 115 127 86 138 524
2022/20232.925 334 398 220 282 285 387 37 229 479 49 190 35
2023/20242.469 221 223 285 193 360 427 63 115 106 96 132 248
2024/20256.733 82 252 109 397 552 730 649 299 735 864 710 1.354
2025/20268.439 532 896 1.093 724 855 669 1.287 420 548 817 308 290
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 32.162